Coronary stenting with MGuard: from conception to human trials

Cardiovascular Revascularization Medicine

Volumn 9, Issue 2, 2008, Pages 88-94

  Kaluski, Edo ^a   Tsai, Steve ^a   Klapholz, Marc ^a  

^a Loyola University Medical Center   (United States)

Author keywords

Emboli protection device; Stent thrombosis, Restenosis

Indexed keywords

DACRON; POLYETHYLENE; POLYMER;

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; CORONARY ARTERY ANEURYSM; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; EMBOLISM; EQUIPMENT DESIGN; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KIDNEY ARTERY EMBOLIZATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROCESS DESIGN; PROTECTIVE EQUIPMENT; RENAL PROTECTION; RESTENOSIS; REVIEW; SAFETY; SURFACE PROPERTY; THROMBOEMBOLISM; TREATMENT FAILURE;

ANIMALS; CORONARY ANGIOGRAPHY; CORONARY VESSELS; EMBOLISM; EQUIPMENT DESIGN; EQUIPMENT SAFETY; HUMANS; HYPERPLASIA; POLYETHYLENE TEREPHTHALATES; STENTS; TUNICA INTIMA;

EID: 43349093631     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2007.12.002     Document Type: Review

References (46)

1. Gorog D., Foale R., and Malik I. Distal myocardial protection during percutaneous coronary intervention: when and where?. J Am Coll Cardiol 46 8 (2005) 1434-1445
2. Eskandari M., Najjar S., Matsumura J., Kibbe M., and Morasch M. Technical limitations of carotid filter embolic protection devices. Ann Vasc Surg 21 4 (2007) 403-407
3. Silber S., Albertsson P., Aviles F., Camici P., Colombo A., Hamm C., Jorgensen E., Marco J., Nordrehaug J., Ruzyllo W., Urban P., Stone G., and Wijns W. Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 8 (2005) 804-847
4. American College of Cardiology Foundation, American Society of Interventional & Therapeutic Neuroradiology, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Angiography and Interventions, Bates E., Babb J., Casey Jr. D., Cates C., Duckwiler G., Feldman T., Gray W., Ouriel K., Peterson E., Rosenfield K., Rundback J., Safian R., Sloan M., and White C. ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol 49 1 (2007) 126-170
5. Liistro F., and Di Mario C. Carotid artery stenting. Heart 89 8 (2003) 944-948
6. Baim D., Wahr D., George B., Leon M., Greenberg J., Cutlip D., Kaya U., Popma J., Ho K., and Kuntz R. Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105 11 (2002) 1285-1290
7. Lacroix V., Hammer F., Astarci P., Duprez T., Grandin C., Cosnard G., Peeters A., and Verhelst R. Ischemic cerebral lesions after carotid surgery and carotid stenting. Eur J Vasc Endovasc Surg 33 4 (2006) 430-435
8. Roh H., Byun H., Ryoo J., Na D., Moon W., Lee B., and Kim D. Prospective analysis of cerebral infarction after carotid endarterectomy and carotid artery stent placement by using diffusion-weighted imaging. Am J Neuroradiol 26 2 (2005) 376-384
9. Tedesco M., Lee J., Dalman R., Lane B., Loh C., Haukoos J., Rapp J., and Coogan S. Postprocedural microembolic events following carotid surgery and carotid angioplasty and stenting. J Vasc Surg 46 2 (2007) 244-250 Electronic publication 2007 Jun 27
10. Powell R., Alessi C., Nolan B., Rzucidlo E., Fillinger M., Walsh D., Wyers M., Zwolak R., and Cronenwett J. Comparison of embolization protection device-specific technical difficulties during carotid artery stenting. J Vasc Surg 44 1 (2006) 56-61
11. Kim S., Roh H., Jeon P., Kim K., Lee K., Byun H., Moon W., Kim G., Kim Y., and Kim D. Cerebral ischemia detected with diffusion-weighted MR imaging after protected carotid artery stenting: comparison of distal balloon and filter device. Korean J Radiol 8 4 (2007) 276-285
12. Zwenneke Flach H., Ouhlous M., Hendriks J., van Sambeek M., Veenland J., van Dijk L., and van der Lugt A. Diffusion weighted imaging to compare different cerebral protection devices in carotid stenting. Eurointervention 3 (2007) 243-248
13. Kastrup A., Nagele T., Groschel K., Schmidt F., Vogler E., Schulz J., and Ernemann U. Incidence of new brain lesions after carotid stenting with and without cerebral protection. Stroke 37 9 (2006) 2312-2316
14. Stone G., Webb J., Cox D., Brodie B., Qureshi M., Kalynych A., Turco M., Schultheiss H., Dulas D., Rutherford B., Antoniucci D., Krucoff M., Gibbons R., Jones D., Lansky A., and Mehran R. Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293 9 (2005) 1063-1072
15. Limbruno U., and De Caterina R. EMERALD, AIMI, and PROMISE: is there still a potential for embolic protection in primary PCI?. Eur Heart J (2006) 55-63
16. Muramatsu T., Kozuma K., Tsukahara R., Ito Y., Fujita N., Suwa S., Koyama S., Saitoh M., Kamiya H., Nakamura M., and for the ASPARAGUS Trial Investigators. Comparison of myocardial perfusion by distal protection before and after primary stenting for acute myocardial infarction: Angiographic and clinical results of a randomized controlled trial. Catheter Cardiovasc Interv (2007) 9 [Electronic publication ahead of print]
17. Matsuo A., Inoue N., Suzuki K., Nakamura R., Fujita H., Miki S., and Yokoi Y. Limitations of using a GuardWire temporary occlusion and aspiration system in patients with acute myocardial infarction: multicenter investigation of coronary artery protection with a distal occlusion device in acute myocardial infarction (MICADO). J Invasive Cardiol 19 3 (2007) 132-138
18. Cura F., Escudero A., Berrocal D., Mendiz O., Trivi M., Fernandez J., Palacios A., Albertal M., Piraino R., Riccitelli M., Gruberg L., Ballarino M., Milei J., Baeza R., Thierer J., Grinfeld L., Krucoff M., O'Neill W., Belardi J., and PREMIAR Investigators. Protection of Distal Embolization in High-Risk Patients with Acute ST-SegmentElevation Myocardial Infarction (PREMIAR). Am J Cardiol 99 3 (2007) 357-363
19. Kunadian B., Dunning J., Vijayalakshmi K., Thornley A., and de Belder M. Meta-analysis of randomized trials comparing anti-embolic devices with standard PCI for improving myocardial reperfusion in patients with acute myocardial Infarction. Catheter Cardiovasc Interv 69 4 (20071) 488-496
20. Grines C., Bonow R., Casey Jr. D., Gardner T., Lockhart P., Moliterno D., O'Gara P., and Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 49 6 (2007) 734-739
21. Division of Cardiovascular, Respiratory, and Neurology Devices, Interventional Cardiology Devices Branch. Guidance for the Submission of Research and Marketing Application for Interventional cardiology Devices: PTCA Catheters, Atherectomy Catheters, Lasers, and Intravascular Stents (1995), Food and Drug Administration, Center for Devices and Radiological Health, US Dept of Health and Human Services May
22. Schwartz R., Edelman E., Carter A., et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 106 (2002) 1867-1873
23. Vollmar B., Bay W., Ozbek C., Heib K., Menger M., and Schieffer H. Experimental intracoronary stenting: comprehensive experience in a porcine model. Lab Anim 32 2 (1998) 191-199
24. Schwartz R., Edelman E., Carter A., Chronos N., Rogers C., Robinson K., Waksman R., Weinberger J., Wilensky R., Jensen D., Zuckerman B., Virmani R., and Consensus Committee. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 106 14 (2002) 1867-1873
25. De Scheerder I., Wang K., Zhou X., Verbeken E., Ping Q., Yanming H., Jianhua H., Szilard M., and Van de Werf F. Neointimal hyperplasia and late pathologic remodeling in a porcine coronary stent model. J Invasive Cardiol 11 1 (1999) 9-12
26. Kaluski E., Groothuis A., Klapholz M., Seifart P., and Edelman E. Coronary stenting with MGuard: feasibility and safety porcine trial. J Invasive Cardiol 19 8 (2007) 326-330
27. Schwartz R., Huber K., Murphy J., Edwards W., Camrud A., Vlietstra R., and Holmes D. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19 2 (1992) 267-274
28. van Gaal W., Choudhury R., Porto I., Channon K., Banning A., Dzavik V., Ramsamujh R., Bui S., and Blackman D. Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol 99 5 (2007) 603-606
29. Mrowietz C., Franke R., Seyfert U., Park J., and Jung F. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents. Clin Hemorheol Microcirc 32 2 (2005) 89-103
30. Tepe G., Schmehl J., Wendel H., Schaffner S., Heller S., Gianotti M., Claussen C., and Duda S. Reduced thrombogenicity of nitinol stents-in vitro evaluation of different surface modifications and coatings. Biomaterials 27 4 (2006) 643-650
31. Schurmann K., Vorwerk D., Uppenkamp R., Klosterhalfen B., Bucker A., and Gunther R. Iliac arteries: plain and heparin-coated Dacron-covered stent-grafts compared with noncovered metal stents-an experimental study. Radiology 203 1 (1997) 55-63
32. Nakayama Y., Nishi S., Ishibashi-Ueda H., Okamoto Y., and Nemoto Y. Development of microporous covered stents: geometrical design of the luminal surface. Int J Artif Organs 28 6 (2005) 600-608
33. Turco M., Buchbinder M., Popma J., Weissman N., Mann T., Doucet S., Johnson Jr. W., Greenberg J., Leadley K., and Russell M. Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial. Catheter Cardiovasc Interv 68 3 (2006) 379-388
34. DeRubertis B., Chaer R., Gordon R., Bell H., Hynecek R., Pieracci F., Karwowski J., Kent K., and Faries P. Determining the quantity and character of carotid artery embolic debris by electron microscopy and energy dispersive spectroscopy. J Vasc Surg 45 4 (2007) 716-724
35. Iyer V., de Donato G., Deloose K., Peeters P., Castriota F., Cremonesi A., Setacci C., and Bosiers M. The type of embolic protection does not influence the outcome in carotid artery stenting. J Vasc Surg 46 2 (2007) 251-256
36. Grunwald I., Papanagiotou P., Struffert T., Politi M., Krick C., Romaike B., Ahlhelm F., and Reith W. Reversal of flow during carotid artery stenting: use of the Parodi antiembolism system. Neuroradiology 49 3 (2007) 237-241
37. Parodi J., Schonholz C., Parodi F., Sicard G., and Ferreira L. Initial 200 cases of carotid artery stenting using a reversal-of-flow cerebral protection device. J Cardiovasc Surg 48 2 (2007) 117-124
38. Gossetti B., Gattuso R., Irace L., Faccenna E., Venosi S., Bozzao L., Fiorelli M., Andreoli R., and Gossetti C. Embolism to the brain during carotid stenting and surgery. Acta Chir Belg 107 2 (2007) 151-154
39. Rapp J., Wakil L., Sawhney R., Pan X., Yenari M., Glastonbury C., Coogan S., and Wintermark M. Subclinical embolization after carotid artery stenting: new lesions on diffusion-weighted magnetic resonance imaging occur postprocedure. J Vasc Surg 45 5 (2007) 867-872
40. Edwards M., Corriere M., Craven T., Pan X., Rapp J., Pearce J., Mertaugh N., and Hansen K. Atheroembolism during percutaneous renal artery revascularization. J Vasc Surg 46 1 (2007) 55-61
41. Edwards M., Craven B., Stafford J., Craven T., Sauve K., Ayerdi J., Geary R., and Hansen K. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg 44 1 (2006) 128-135
42. Corriere M., Crutchley T., and Edwards M. Is embolic protection during renal artery intervention really necessary?. J Cardiovasc Surg 48 4 (2007) 443-453
43. Cacucci M., Catanoso A., Valentini P., Lodi Rizzini A., Agricola P., Pedrinazzi C., and Inama G. Right coronary artery aneurysm: percutaneous treatment with graft-coated stent during the acute phase of myocardial infarction. Int J Cardiol (2007) [Electronic publication ahead of print]
44. Lee M., Nero T., Makkar R., and Wilentz J. Treatment of coronary aneurysm in acute myocardial infarction with AngioJet thrombectomy and JoStent coronary stent graft. J Invasive Cardiol 16 5 (2004) 294-296
45. Antonello M., Frigatti P., Battocchio P., Lepidi S., Cognolato D., Dall'Antonia A., Stramana R., Deriu G., and Grego F. Open repair versus endovascular treatment for asymptomatic popliteal artery aneurysm: results of a prospective randomized study. J Vasc Surg 42 2 (2005) 185-193
46. Corriere M., Sauve K., Ayerdi J., Craven B., Stafford J., Geary R., and Edwards M. Vena cava filters and inferior vena cava thrombosis. J Vasc Surg 45 4 (2007) 789-794